APDA-Funded Research for 2023-2024
Exciting research is underway. Take a look at the innovative projects and inspiring researchers APDA is supporting this year.
George C. Cotzias Fellowship
The George C. Cotzias Fellowship is named in honor of the scientist who had a critical role in developing Levodopa as a treatment for Parkinson’s disease and is awarded with the purpose of encouraging young neurologists to follow in his footsteps.
Gary Ho, MD, PhD
Brigham and Women’s Hospital/Harvard Medical School, Boston, MA
Leveraging protein palmitoylation to correct vesicle trafficking defects in Parkinson’s disease
Krithi Irmady, MD, PhD
Rockefeller University, New York City, NY
RNA regulation in Parkinson’s disease and levodopa-induced dyskinesia
Abby L. Olsen, MD, PhD
University of Pittsburgh, Pittsburgh, PA
Harnessing the untapped therapeutic potential of glia in Parkinson’s disease
Diversity in Parkinson’s Disease Research Grant
The Diversity in Parkinson’s Disease Research Grant is awarded to investigators studying the health disparities or differences among under-represented PD communities.
Karen Hegland, PhD
University of Florida, Gainesville, FL
Low utilization of deep brain stimulation (DBS) therapy among minoritized individuals with Parkinson disease
Laura Andrea Prieto, PhD
University of Wisconsin-Madison, Madison, WI
Physical activity among Latino/a people with Parkinson disease and their care partners
Post-Doctoral Fellowships
This fellowship is awarded to support post-doctoral scientists whose research holds promise to provide new insights into the pathophysiology, etiology, and treatment of PD.
Abdulmunaim Eid, MD
Washington University, St. Louis, MO
The neurobiological basis of Parkinson’s disease clinical subtypes
Dr. Hanna Sas-Nowosielska, PhD
University of Pennsylvania, Philadelphia, PA
Enhancing neuronal resilience to neurodegeneration via the epigenetic-metabolic axis
Research Grants
This grant is awarded to investigators performing innovative PD research at major academic institutions across the United States.
Andrew Arrant, PhD
University of Alabama at Birmingham, Birmingham, AL
Investigating the role of progranulin in synucleinopathy
Briana De Miranda, PhD
University of Alabama at Birmingham, Birmingham, AL
Cdk5 inhibition as a protective mechanism against environmental toxicant induced Parkinson’s disease
Jeff Eells, PhD
East Carolina University, Greenville, NC
Mechanisms of SARS-CoV-2 infection induced dopamine neuron damage
Enrico Opri, PhD
The Regents of the University of Michigan, Ann Arbor, MI
Stimulation induced evoked potentials for guided intra and post-operative functional mapping
Nikhil Panicker, PhD
Cleveland Clinic Foundation, Cleveland, OH
Using IPSC models to interrogate Inflammasome-mediated pathogenesis in Parkinson’s Disease
Satya Surabhi, PhD
Albert Einstein College of Medicine, Bronx, NY
The role of Lamp1 in age-related neurodegenerative diseases
William Zeiger, MD, PhD
University of California – Los Angeles, Los Angeles, CA
Mechanisms of posterior cortical circuit dysfunction and cognitive impairment in a mouse model of PD
IN THE NEWS
APDA Awards $1.975 Million in Research Grants.